CUSIP 28176E108 · who reports it, how much, and how much it matters to them
44 of the 720 hedge fund managers we track reported shares of Edwards Lifesciences Corp (NYSE: EW) on Form 13F for 30 June 2026. Between them they reported USD 2.4bn. The largest position belongs to Artisan Partners, at USD 599m. The manager with the most riding on it is Ninety One North America, where it is 2.6% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Artisan Partners1 fund on PPLI.com | USD 599m | 0.9% |
| 2 | Citadel Advisors32 funds on PPLI.com | USD 362m | 0.0% |
| 3 | Millennium Management6 funds on PPLI.com | USD 324m | 0.1% |
| 4 | Holocene Advisors2 funds on PPLI.com | USD 284m | 0.6% |
| 5 | POINT72 Asset Management17 funds on PPLI.com | USD 160m | 0.2% |
| 6 | Two Sigma Investments35 funds on PPLI.com | USD 138m | 0.1% |
| 7 | Polar Capital LLP26 funds on PPLI.com | USD 100m | 0.2% |
| 8 | Orbimed Advisors1 fund on PPLI.com | USD 76m | 1.4% |
| 9 | Adage Capital Management1 fund on PPLI.com | USD 65m | 0.1% |
| 10 | Ninety One North America3 funds on PPLI.com | USD 56m | 2.6% |
| 11 | Balyasny Asset Management25 funds on PPLI.com | USD 41m | 0.1% |
| 12 | Marshall Wace LLP84 funds on PPLI.com | USD 31m | 0.0% |
| 13 | Bridgewater Associates45 funds on PPLI.com | USD 25m | 0.1% |
| 14 | PFM Health Sciences3 funds on PPLI.com | USD 23m | 1.9% |
| 15 | Verition Fund Management3 funds on PPLI.com | USD 18m | 0.1% |
| 16 | Schonfeld Strategic Advisors30 funds on PPLI.com | USD 17m | 0.1% |
| 17 | Freestone Grove Partners1 fund on PPLI.com | USD 15m | 0.1% |
| 18 | IFM Investors Pty7 funds on PPLI.com | USD 13m | 0.1% |
| 19 | Engineers Gate Manager1 fund on PPLI.com | USD 12m | 0.2% |
| 20 | CIBC Asset Management69 funds on PPLI.com | USD 12m | 0.0% |
| 21 | Armistice Capital1 fund on PPLI.com | USD 8.9m | 0.1% |
| 22 | Hudson Bay Capital Management8 funds on PPLI.com | USD 8.1m | 0.0% |
| 23 | Kinneret Advisory7 funds on PPLI.com | USD 5.7m | 0.5% |
| 24 | Brevan Howard Capital Management39 funds on PPLI.com | USD 3.2m | 0.0% |
| 25 | Palo Alto Investors6 funds on PPLI.com | USD 3m | 0.4% |
| 26 | Exoduspoint Capital Management7 funds on PPLI.com | USD 2.8m | 0.0% |
| 27 | Squarepoint Ops7 funds on PPLI.com | USD 2.5m | 0.0% |
| 28 | LMR Partners2 funds on PPLI.com | USD 2.3m | 0.0% |
| 29 | Jain Global1 fund on PPLI.com | USD 2.2m | 0.0% |
| 30 | Landscape Capital Management4 funds on PPLI.com | USD 2.1m | 0.1% |
| 31 | Renaissance Technologies13 funds on PPLI.com | USD 1.9m | 0.0% |
| 32 | Grantham Mayo Van Otterloo & Co1 fund on PPLI.com | USD 1.9m | 0.0% |
| 33 | Suvretta Capital Management4 funds on PPLI.com | USD 1.7m | 0.0% |
| 34 | Campbell & Company Investment Adviser8 funds on PPLI.com | USD 1.6m | 0.1% |
| 35 | Trust Asset Management4 funds on PPLI.com | USD 1.1m | 0.0% |
| 36 | ISAM Funds (UK)1 fund on PPLI.com | USD 1.1m | 0.8% |
| 37 | Fulcrum Asset Management LLP7 funds on PPLI.com | USD 688,000 | 0.1% |
| 38 | Persistent Asset Partners10 funds on PPLI.com | USD 438,000 | 0.1% |
| 39 | Corient Ia11 funds on PPLI.com | USD 291,000 | 0.3% |
| 40 | Seelaus Asset Management8 funds on PPLI.com | USD 273,000 | 0.2% |
| 41 | Entrypoint Capital1 fund on PPLI.com | USD 250,000 | 0.1% |
| 42 | Edgestream Partners5 funds on PPLI.com | USD 209,000 | 0.0% |
| 43 | Battery Global Advisors16 funds on PPLI.com | USD 130,000 | 0.1% |
| 44 | Walleye Capital8 funds on PPLI.com | USD 37,631 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Ninety One North America | USD 56m | 2.6% |
| 2 | PFM Health Sciences | USD 23m | 1.9% |
| 3 | Orbimed Advisors | USD 76m | 1.4% |
| 4 | Artisan Partners | USD 599m | 0.9% |
| 5 | ISAM Funds (UK) | USD 1.1m | 0.8% |
| 6 | Holocene Advisors | USD 284m | 0.6% |
| 7 | Kinneret Advisory | USD 5.7m | 0.5% |
| 8 | Palo Alto Investors | USD 3m | 0.4% |
| 9 | Corient Ia | USD 291,000 | 0.3% |
| 10 | Polar Capital LLP | USD 100m | 0.2% |
Edwards Lifesciences Corp trades under the symbol EW on the New York Stock Exchange. Its CUSIP, the code used on Form 13F, is 28176E108.
44 of the 720 hedge fund managers PPLI.com tracks reported Edwards Lifesciences Corp shares on Form 13F for 30 June 2026. The largest reported positions were held by Artisan Partners (USD 599m), Citadel Advisors (USD 362m), Millennium Management (USD 324m), Holocene Advisors (USD 284m) and POINT72 Asset Management (USD 160m).
44 managers in our coverage reported it, and between them they run 571 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Ninety One North America, where the position was 2.6% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Edwards Lifesciences Corp or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.